Cargando…
Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids
Two commercial real-time PCR assays for the detection of Pneumocystis jirovecii were compared, the quantitative RealStar P. jirovecii assay and the qualitative DiaSorin P. jirovecii assay, the latter of which can be used without nucleic acid extraction. Archived bronchoalveolar lavage (BAL) specimen...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434167/ https://www.ncbi.nlm.nih.gov/pubmed/37260378 http://dx.doi.org/10.1128/spectrum.01021-23 |
_version_ | 1785091823303131136 |
---|---|
author | Belanger, Corrie R. Locher, Kerstin Velapatino, Billie Dufresne, Philippe J. Eckbo, Eric Charles, Marthe |
author_facet | Belanger, Corrie R. Locher, Kerstin Velapatino, Billie Dufresne, Philippe J. Eckbo, Eric Charles, Marthe |
author_sort | Belanger, Corrie R. |
collection | PubMed |
description | Two commercial real-time PCR assays for the detection of Pneumocystis jirovecii were compared, the quantitative RealStar P. jirovecii assay and the qualitative DiaSorin P. jirovecii assay, the latter of which can be used without nucleic acid extraction. Archived bronchoalveolar lavage (BAL) specimens (n = 66), previously tested by molecular methods, were tested by both assays, and the results were compared to the respective original result. The RealStar P. jirovecii assay demonstrated good positive percent agreement (PPA) (90% [95% confidence interval (CI), 72 to 97%]; 27/30) and negative percent agreement (NPA) (100% [95% CI, 88 to 100%]; 36/36) with the reference method. The DiaSorin P. jirovecii assay concordantly detected P. jirovecii in 19 of 24 positive BAL samples (PPA = 73% [95% CI, 52 to 88%]). All negative BAL samples gave concordant results (NPA = 100% [95% CI, 87 to 100%]; 34/34). Discordant results occurred mostly in samples with low fungal loads. In conclusion, the RealStar assay demonstrated good concordance with reference results, and the DiaSorin P. jirovecii assay performed well for negative BAL and positive BAL samples with P. jirovecii concentrations of greater than 260 copies/mL. IMPORTANCE Pneumonia, caused by the opportunistic fungus Pneumocystis jirovecii, poses a significant risk for immunocompromised individuals. Laboratory testing for P. jirovecii is progressively shifting toward the use of molecular tests such as real-time PCR; however, this is often performed at reference laboratories. Many frontline laboratories are looking into improving their service and reducing turnaround times for obtaining P. jirovecii results by bringing molecular P. jirovecii testing in-house. We evaluated and compared two commercial real-time PCR assays with different workflows for the detection of P. jirovecii from bronchoalveolar lavage specimens. The RealStar P. jirovecii assay requires nucleic acid extraction and provides a quantification of fungal load for positive samples. The DiaSorin P. jirovecii assay offers a simple workflow without nucleic extraction from patient samples and qualitative results. Results from this study provide valuable information on performance and workflow considerations for laboratories that wish to implement P. jirovecii molecular testing. |
format | Online Article Text |
id | pubmed-10434167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-104341672023-08-18 Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids Belanger, Corrie R. Locher, Kerstin Velapatino, Billie Dufresne, Philippe J. Eckbo, Eric Charles, Marthe Microbiol Spectr Research Article Two commercial real-time PCR assays for the detection of Pneumocystis jirovecii were compared, the quantitative RealStar P. jirovecii assay and the qualitative DiaSorin P. jirovecii assay, the latter of which can be used without nucleic acid extraction. Archived bronchoalveolar lavage (BAL) specimens (n = 66), previously tested by molecular methods, were tested by both assays, and the results were compared to the respective original result. The RealStar P. jirovecii assay demonstrated good positive percent agreement (PPA) (90% [95% confidence interval (CI), 72 to 97%]; 27/30) and negative percent agreement (NPA) (100% [95% CI, 88 to 100%]; 36/36) with the reference method. The DiaSorin P. jirovecii assay concordantly detected P. jirovecii in 19 of 24 positive BAL samples (PPA = 73% [95% CI, 52 to 88%]). All negative BAL samples gave concordant results (NPA = 100% [95% CI, 87 to 100%]; 34/34). Discordant results occurred mostly in samples with low fungal loads. In conclusion, the RealStar assay demonstrated good concordance with reference results, and the DiaSorin P. jirovecii assay performed well for negative BAL and positive BAL samples with P. jirovecii concentrations of greater than 260 copies/mL. IMPORTANCE Pneumonia, caused by the opportunistic fungus Pneumocystis jirovecii, poses a significant risk for immunocompromised individuals. Laboratory testing for P. jirovecii is progressively shifting toward the use of molecular tests such as real-time PCR; however, this is often performed at reference laboratories. Many frontline laboratories are looking into improving their service and reducing turnaround times for obtaining P. jirovecii results by bringing molecular P. jirovecii testing in-house. We evaluated and compared two commercial real-time PCR assays with different workflows for the detection of P. jirovecii from bronchoalveolar lavage specimens. The RealStar P. jirovecii assay requires nucleic acid extraction and provides a quantification of fungal load for positive samples. The DiaSorin P. jirovecii assay offers a simple workflow without nucleic extraction from patient samples and qualitative results. Results from this study provide valuable information on performance and workflow considerations for laboratories that wish to implement P. jirovecii molecular testing. American Society for Microbiology 2023-06-01 /pmc/articles/PMC10434167/ /pubmed/37260378 http://dx.doi.org/10.1128/spectrum.01021-23 Text en Copyright © 2023 Belanger et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Belanger, Corrie R. Locher, Kerstin Velapatino, Billie Dufresne, Philippe J. Eckbo, Eric Charles, Marthe Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids |
title | Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids |
title_full | Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids |
title_fullStr | Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids |
title_full_unstemmed | Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids |
title_short | Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids |
title_sort | quick versus quantitative: evaluation of two commercial real-time pcr assays for the detection of pneumocystis jirovecii from bronchoalveolar lavage fluids |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434167/ https://www.ncbi.nlm.nih.gov/pubmed/37260378 http://dx.doi.org/10.1128/spectrum.01021-23 |
work_keys_str_mv | AT belangercorrier quickversusquantitativeevaluationoftwocommercialrealtimepcrassaysforthedetectionofpneumocystisjiroveciifrombronchoalveolarlavagefluids AT locherkerstin quickversusquantitativeevaluationoftwocommercialrealtimepcrassaysforthedetectionofpneumocystisjiroveciifrombronchoalveolarlavagefluids AT velapatinobillie quickversusquantitativeevaluationoftwocommercialrealtimepcrassaysforthedetectionofpneumocystisjiroveciifrombronchoalveolarlavagefluids AT dufresnephilippej quickversusquantitativeevaluationoftwocommercialrealtimepcrassaysforthedetectionofpneumocystisjiroveciifrombronchoalveolarlavagefluids AT eckboeric quickversusquantitativeevaluationoftwocommercialrealtimepcrassaysforthedetectionofpneumocystisjiroveciifrombronchoalveolarlavagefluids AT charlesmarthe quickversusquantitativeevaluationoftwocommercialrealtimepcrassaysforthedetectionofpneumocystisjiroveciifrombronchoalveolarlavagefluids |